Hepatitis B Treatment Market Analysis, Industry Growth, Demand Overview and Global Forecast to 2024

Market Highlights:
The global Hepatitis B Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.
Hepatitis B is a viral infection caused by a hepatitis B virus. This infection lasts for a longer period and can cause many other complications, such as scarring in the liver, liver cancer or liver failure. The person suffering from hepatitis B faces various symptoms such as fever, fatigue, nausea, and muscle aches. The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more. The key factors contributing the market growth are growing geriatric population, increasing the prevalence of viral infection and growing sexually transmitted diseases among the population contribute to driving the market growth. The World Hepatitis Alliance (WHA), 2017 reported that 52 million children across the world are living with viral hepatitis. Such a huge population suffering from Hepatitis boosts the market growth.
However, the factor such as the side effects or complication caused due to treatment may hamper the market growth. 
Access Full Report Details and TOC Exclusively  @ https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817
Key Players:
·         Accord Healthcare Inc
·         Apotex Corp
·         Arbutus Biopharma
·         Arrowhead Pharma
·         Aurobindo Pharma Limited
·         Bristol-Myers Squibb Company
·         Gilead Sciences
·         GlaxoSmithKline
·         Lupin Pharmaceuticals
·         Merck & Co
Segmentation:
·         The global hepatitis B treatment market is segmented on the basis of type, treatment, distribution channel, and region.
·         Based on type, the market is segmented into acute and chronic.
·         On the basis of treatment, the global hepatitis B treatment market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others.
·         By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.
Regional Analysis:
The Americas dominates the global market for hepatitis B treatment. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market. The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.
Following similar trends, Europe stood second in the global hepatitis B treatment market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global hepatitis B treatment market in 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth.


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote
Read more

Surgical Drapes and Gowns Market is Growing Dynamically at a Speedy CAGR of 4.4% During Forecast 2018-2023

Market Overview: Market Research Future Reports have accumulated study insights and states that the global surgical drapes and gowns market size is expected to expand significantly by the year 2023 as it already held a valuation of USD 2.23 billion in 2017. Now that with the current scenario, it has been observed that the surgical drapes and gowns market is set to proliferate at a CAGR of 4.4% over the forecast period. Surgical Drapes and Gowns Market Share   Held Valuation Up to USD 2.23 Billion in 2017 and Expected to Proliferate in Coming Years Says Global Top Manufacturers A gown and drape have found its immense importance with its usage in the surgical world. These gowns and drapes are useful in reducing the risk of disease. These are supplied by healthcare professionals for minimizing the exposure of transfer of infection while maintaining sterility of spaces. Since its optimum usage in hospitals and clinics globally, it is gaining significant traction in recent time.
Read more

Dental Lasers Market Growth Values, Advanced Share, Demand Overview and Industry Forecast to 2023

Market Overview: The global Dental Lasers Market , as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period ( 2017-2023 ). Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. Competitive Dashboard: ·          Biolase ·          AMD Lasers ·          Convergent Dental ·          Cao Group ·          Fotona D.D ·          Danaher Corporation- Kavo Dental GmbH ·          Millennium Dental Technologies ·          Ivoclar Vivadent AG ·          Syneron Dental Lasers-Syneron Medical Ltd
Read more